Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 4 43-4, 1998, Pages

  Duffy, Stephen J ^a   Tran, Binh T ^a   New, Gishel ^a   Tudball, Ronald N ^a   Esler, Murray D ^b   Harper, Richard W ^a   Meredith, Ian T ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Aspirin; Eicosanoids; Regional blood flow; Vasoconstriction; Vasodilation

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; ACETYLSALICYLIC ACID; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; REST; VASOCONSTRICTION; VASODILATATION;

EID: 33750858136     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.4.h1174     Document Type: Article

References (51)

1. Altman, J. D., D. Dulas, T. Pavek, and R. J. Bache. Effect of aspirin on coronary collateral blood flow. Circulation 87: 583-589, 1993.
2. Altman, J., D. Dulas, T. Pavek, D. D. Laxson, D. C. Homans, and R. J. Bache. Endothelial function in well-developed canine coronary collateral vessels. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H567-H572, 1993.
3. Beaty, O., and D. E. Donald. Contribution of prostaglandins to muscle blood flow in anesthetized dogs at rest, during exercise, and following inflow occlusion. Circ. Res. 44: 67-75, 1979.
4. Carlsson, I., and A. Wennmalm. Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. Prostaglandins 26: 241-252, 1983.
5. Christ-Hazelhof, E., and D. H. Nugteren. Prostacyclin is not a circulating hormone. Prostaglandins 22: 739-746, 1981.
6. Claria, J., and C. N. Serhan. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92: 9475-9479, 1995.
7. Cleland, J. G., C. J. Bulpitt, R. H. Falk, I. N. Findlay, C. M. Oakley, G. Murray, P. A. Poole-Wilson, C. R. Prentice, and G. C. Sutton. Is aspirin safe for patients with heart failure? Br. Heart J. 74: 215-219, 1995.
8. Coles, D. R., K. E. Cooper, R. F. Mottram, and J. V. Occleshaw. The source of blood samples withdrawn from deep forearm veins via catheters passed upstream from the median cubital vein. J. Physlol. 142: 323-328, 1958.
9. Coyle, M. G., W. Oh, K. H. Petersson, and B. S. Stonestreet. Effects of indomethacin on brain blood flow, cerebral metabolism, and sagittal sinus prostanoids after hypoxia. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1450-H1459, 1995.
10. De Nucci, G., R. J. Gryglewski, T. D. Warner, and J. R. Vane. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. USA 85: 2334-2338, 1988.
11. Engelke, K. A., J. R. Halliwill, D. N. Proctor, N. M. Dietz, and M. J. Joyner. Contribution of nitric oxide and prostaglandins to reactive hyperemia in the human forearm. J. Appl. Physiol. 81: 1807-1814, 1996.
12. Esler, M., G. Jackman, A. Bobik, D. Kelleher, G. Jennings, P. Leonard, H. Skews, and P. Korner. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 25: 1461-1470, 1979.
13. FitzGerald, G. A., A. R. Brash, P. Falardeau, and J. A. Oates. Estimated rate of prostacyclin secretion into the circulation of normal man. J. Clin. Invest. 68: 1272-1275, 1981.
14. Friedman, P. L., E. J. Brown, Jr., S. Gunther, R. W. Alexander, W. H. Barry, G. H. Mudge, Jr., and W. Grossman. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N. Engl. J. Med. 305: 1171-1175, 1981.
15. Granstrom, E., and H. Kindahl. A critical approach to eicosanoid assay. Adv. Prostaglandin Thromboxane Leukot. Res. 21A: 295-302, 1991.
16. Grossman, W. Blood flow measurement: the cardiac output. In: Cardiac Catheterization, Angiography, and Intervention (5th ed.), edited by D. S. Baim and W. Grossman. Baltimore, MD: Williams and Wilkins, 1996, p. 109-124.
17. Gryglewski, R. J. Interactions between nitric oxide and prostacyclin. Semin. Thromb. Hemost. 19: 158-166, 1993.
18. Gryglewski, R. J., R. M. Botting, and J. R. Vane. Prostacyclin: from discovery to clinical application. In: Cardiovascular Significance of Endothelium-Derived Vasoactive Factors, edited by G. M. Rubanyi. Mount Kisco, NY: Futura, 1991, p. 3-37.
19. Herbaczynska-Cedro, K., J. Staszewska-Barczak, and H. Janczewska. Muscular work and the release of prostaglandin-like substances. Cardiovasc. Res. 10: 413-420, 1976.
20. Hintze, T. H., and G. Kaley. Prostaglandins and the control of blood flow in the canine myocardium. Circ. Res. 40: 313-320, 1977.
21. Hokanson, D. E., D. S. Sumner, and D. E. Strandness. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans. Biomed. Eng. 22: 25-29, 1975.
22. Insel, P. A. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics (9th ed.), edited by J. G. Hardman, A. G. Gilman, and L. E. Limbird. New York: McGraw-Hill, 1996, p. 617-657.
23. Jaffe, E. A., and B. B. Weksler. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J. Clin. Invest. 63: 532-535, 1979.
24. Janczewska, H., and K. Herbaczynska-Cedro. Effect of indomethacin on vascular responses to vasoactive agents in working skeletal muscles of the dog. Pol. J. Pharmacol. Pharm. 26: 159-166, 1974.
25. Kilbom, A., and A. Wennmalm. Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. J. Physiol. (Lond.) 257: 109-121, 1976.
26. Linder, L., W. Kiowski, F. R. Buhler, and T. F. Luscher. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81: 1762-1767, 1990.
27. Luscher, T. F., C. M. Boulanger, Z. Yang, G. Noll, and Y. Dohi. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 87: V-36-V-44, 1993.
28. Mason, W. D., and N. Winer. Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions. J. Pharm. Sci. 70: 262-265, 1981.
29. Masotti, G., G. Galanti, L. Poggesi, R. Abbate, and G. G. Neri Serneri. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2: 1213-1217, 1979.
30. Meredith, I. T., K. E. Currie, T. J. Anderson, M. A. Roddy, P. Ganz, and M. A. Creager. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1435-H1440, 1996.
31. Messina, E. J., R. Weiner, and G. Kaley. Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat. Circ. Res. 37: 430-437, 1975.
32. 2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11: 323-344, 1977.
33. Nowak, J., and A. Wennmalm. Human forearm and kidney conversion of arachidonic acid to prostaglandins. Acta Physiol. Scand. 106: 307-312, 1979.
34. 2 formation (1). N. Engl. J. Med. 319: 689-698, 1988.
35. Piper, P. J. Pharmacology of leukotrienes. Br. Med. Bull. 39: 255-259, 1983.
36. Powell, W. S. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 86: 467-477, 1982.
37. Quyyumi, A. A., N. Dakak, N. P. Andrews, D. M. Gilligan, J. A. Panza, and R. O. R. Cannon. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92: 320-326, 1995.
38. Ritter, J. M., S. E. Barrow, I. A. Blair, and C. T. Dollery. Release of prostacyclin in vivo and its role in man. Lancet 1: 317-319, 1983.
39. Rowland, M., S. Riegelman, P. A. Harris, S. D. Sholkoff, and E. J. Eyring. Kinetics of acetylsalicylic acid disposition in man. Nature 215: 413-414, 1967.
40. Shepherd, J. T. Circulation to skeletal muscle. In: Handbook of Physiology. The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. Bethesda, MD: Am. Physiol. Soc., 1983, sect. 2, vol. III, pt. 1, chapt. 11, p. 319-370.
41. Smith, L. J. Leukotrienes in asthma. Arch. Intern. Med. 156: 2181-2189, 1996.
42. Smith, W. L. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F181-F191, 1992.
43. Ting, H. H., F. K. Timimi, K. S. Boles, S. J. Creager, P. Ganz, and M. A. Creager. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97: 22-28, 1996.
44. Trinder, P. Rapid determination of salicylate in biological fluids. Biochem. J. 57: 301-303, 1953.
45. Vallance, P., J. Collier, and S. Moncada. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989.
46. Vane, J. R., E. E. Anggard, and R. M. Botting. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323: 27-36, 1990.
47. Vanhoutte, P. M., T. J. Verbeuren, and R. C. Webb. Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol. Rev. 61: 151-247, 1981.
48. Von Voss, H., U. Gobel, C. Petrich, and J. Putter. Pharmacokinetic investigations in adult humans after parenteral administration of the lysine salt of acetyl-salicylic acid. Klin. Wochenschr. 56: 1119-1123, 1978.
49. Wilson, J. R., and S. C. Kapoor. Contribution of prostaglandins to exercise-induced vasodilation in humans. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H171-H175, 1993.
50. Young, E. W., and H. V. Sparks. Prostaglandin E release from dog skeletal muscle during restricted flow exercise. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H596-H599, 1979.
51. Young, E. W., and H. V. Sparks. Prostaglandins and exercise hyperemia of dog skeletal muscle. Am. J. Physiol. 238 (Heart Circ. Physiol. 7): H190-H195, 1980.